This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Liver Transplantation  • Gastrointestinal Diseases  • Liver/ Biliary Tract/ Pancreatic Diseases  • Hypertension  • Alert me on articles by topic

J. Michael Henderson, MD
Cleveland, Ohio

Arch Surg. 1999;134:420.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The article by Jenkins et al reports a single center's experience with distal splenorenal shunt (DSRS) over a 12-year period. It helps to define the effect of shunt surgery in the overall scheme of management of patients with portal hypertension, variceal bleeding, and liver disease. The authors define which patients have been selected for shunts, what outcomes have been achieved, and where DSRS fits in the scheme of endoscopic therapy, transjugular intrahepatic portosystemic shunt (TIPS), and transplantations.

Child class A and B patients with recurrent variceal bleeding were candidates for DSRS, and as reported in other surgical series, the authors achieved a low operative mortality rate (6.2%) and good long-term survival rates, 86% at 1 year and 74% at 5 years. The rebleeding rate was 6.8%, the encephalopathy rate was 14.9%, and the transplantation rate was 13.6%, with a median follow-up time of approximately 5 years, . . . [Full Text of this Article]

RELATED ARTICLE

Distal Splenorenal Shunt: Role, Indications, and Utility in the Era of Liver Transplantation
Roger L. Jenkins, Roberto Gedaly, James J. Pomposelli, Elizabeth A. Pomfret, Fredric Gordon, and W. David Lewis
Arch Surg. 1999;134(4):416-420.
ABSTRACT | FULL TEXT